Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)

Clinical trial condition

Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)

Explore clinical trials studying Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia) trial results

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

NCT02242045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +24 more
Locations: Aichi, Japan

Miyagi, Japan

Tokyo, Japan

View Trial Details